Home » Topics » Conferences

Conferences
RSS

German scientists synthesize novel apoptosis-inducing agents

June 26, 1998

Verapamil prodrug enhances activity of cytotoxic agents in resistant cell lines

June 26, 1998

Interim report on phase I testing of bizelesin, a bifunctional alkylating agent

June 26, 1998

Favorable early clinical trial results presented for AERx-delivered insulin at diabetes congress

June 25, 1998

Flavone acetic acid analogue suppresses tumor blood perfusion, patient study shows

June 25, 1998

First patients being treated with bombesin/GRP antagonist RC-3095

June 25, 1998

Cationic peptides exert selective antitumor activity against sensitive and resistant cell lines

June 25, 1998

CMB-401, an immunoconjugate for the targeted treatment of EOC

June 25, 1998

Anthracenedione analogue BBR-2778 moves to phase I testing

June 25, 1998

Positive phase II results for GMK vaccine presented at NCI-EORTC meeting

June 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...